Cancer Drug Safety and Public Health Policy: A Changing Landscape

Author:   Charles Bennett ,  Courtney Lubaczewski ,  Bartlett Witherspoon
Publisher:   Springer International Publishing AG
Edition:   2022 ed.
Volume:   184
ISBN:  

9783031044014


Pages:   167
Publication Date:   01 December 2022
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $310.47 Quantity:  
Add to Cart

Share |

Cancer Drug Safety and Public Health Policy: A Changing Landscape


Add your own review!

Overview

Full Product Details

Author:   Charles Bennett ,  Courtney Lubaczewski ,  Bartlett Witherspoon
Publisher:   Springer International Publishing AG
Imprint:   Springer International Publishing AG
Edition:   2022 ed.
Volume:   184
Weight:   0.474kg
ISBN:  

9783031044014


ISBN 10:   3031044010
Pages:   167
Publication Date:   01 December 2022
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Fluoroquinolone-Associated Disability and Other Fluoroquinolone Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent Years.- Biosimilar Epoetin in the United States: A View from the Southern Network on Adverse Reactions.- Policing of Drug Safety Information under the False Claims Act.- Translating Research Into Health Policy: The Citizen Petition Experience with the Food and Drug Administration.- Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions.- Was there Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occuring in Copenhagen.- Rituximab-associated Progressive Multifocal Leukoencephalopathy: A fatal adverse drug reaction.- Maximum Accuracy Machine Learning Statistical Analysis – A Novel Approach.- Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at Work.- Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019):A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).- Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature Birth.- Investigating Novel Genetic Fluoroquinolone Associated Disorders.

Reviews

Author Information

Charles L Bennett, MD PhD MPP, SmartState Chair and Frank P and Josie M Fletcher Chair of Medication Safety and Efficacy and Director, SmartState Center for Medication Safety and Efficacy, is also a Visiting Scholar at the City of Hope National Cancer Institute Designated Comprehensive Cancer Center in Duarte, California and is the co-editor of this book, Cancer Policy (2nd Edition). Dr. Bennett is a Phi Beta Kappa and High Honors graduate in mathematics from Swarthmore College, earned his medical degree in 1981 from the University of Pennsylvania Perelman School of Medicine, and completed internal medicine, hematology, and oncology training at the Michael Reese Hospital and the University of Chicago Pritzger School of Medicine before completing his PhD and Masters In Public Policy degrees with honors in social science at the RAND Pardee Graduate School of Public Policy in Santa Monica, California. He has led a 20- year National Institutes of Health funded pharmacovigilance called the Research on Adverse Drug events And Reports (RADAR) and subsequently called to Southern Network on Adverse drug Reactions (SONAR) at the University of South Carolina College of Pharmacy.  Courtney Lubaczewski is a fourth-year undergraduate at the University of South Carolina Honors College and the co-editor of Cancer Policy with Charles L Bennett MD PhD MPP. She was a co-author on the 2021 PLOS One article on harms to physicians who report serious adverse drug reactions. Bartlett Witherspoon, MBA is a third-year medical student at the Medical University of South Carolina and a graduate of Vanderbilt University’s Master’s in Business Administration program. He is an active co-investigator with Dr. Bennett and the SONAR project and has been a lead co-investigator on published manuscripts on fluoroquinolone-associated disability and on biosimilar oncology products.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List